Trial intelligence / Profile preview

Estradiol for Hypogonadal Women With Cystic Fibrosis and Osteopenia

NCT03724955Phase 4Withdrawn

Sponsor
Emory University
Start
Apr 2019
Primary completion
Jun 2021
Modality
Hormone, Biologic
Countries
1
01

Overview

A Phase 4 trial of estradiol in Hypogonadism, bone disease, sponsored by Emory University. Planned start Apr 2019; status: withdrawn.

02

Drugs

estradiol
03

Conditions

Hypogonadismbone disease

Beyond the preview

Go deeper on NCT03724955.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03724955.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call